A detailed history of Versant Capital Management, Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,605 shares of TXG stock, worth $25,455. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,605
Previous 205 682.93%
Holding current value
$25,455
Previous $3,000 1100.0%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$15.71 - $23.49 $21,994 - $32,886
1,400 Added 682.93%
1,605 $36,000
Q2 2024

Jul 05, 2024

BUY
$19.45 - $37.37 $3,987 - $7,660
205 New
205 $3,000
Q1 2022

Apr 29, 2022

SELL
$55.7 - $145.79 $111 - $291
-2 Closed
0 $0
Q4 2021

Jan 06, 2022

BUY
$135.05 - $182.59 $270 - $365
2 New
2 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.